Previous Page  9 / 16 Next Page
Information
Show Menu
Previous Page 9 / 16 Next Page
Page Background

9

Septiembre

2011.

Volumen

10

-

N

°

46

Es importante indagar estos factores dentro

de la evaluación de un paciente asmático y

detectar precozmente el riesgo de no adherencia

para reforzar indicaciones o realizar alguna

intervención enfocada a las características

especiales de cada caso.

Este artículo ha sido revisado con la colaboración

del Dr. Francisco Prado A., académico del

Departamento de Pediatría de la Universidad

de Chile.

Referencias:

1.

Astudillo P: Asma infantil en Chile. Neumol Pediatr

2006; 1: 91-93.

2.

Mallol J, Cortez E, Amorales L, et al: Prevalence of asthma in Chilean students. Descriptive study of

24,470

children. ISAAC-Chile.

Rev Méd Chile

2000; 128: 279-85.

3.

Decreto supremo Nº

228

de

2005

del Ministerio de Salud y Ministerio de Hacienda, publicado en el Diario Oficial el

30

de enero

de

2006

y Resolución Exenta Nº

58

de fecha

30

de enero de

2006

del Ministerio de Salud.

4.

Ministerio de Salud. Guía Clínica de Diagnóstico y Tratamiento del Asma en el Menor de

15

años. Minsal

2006

.

5.

World Health Organization (WHO). (

2003

). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland.

6.

Gibson NA et al. Compliance with inhaled asthma medication in preschool children. Thorax,

1995, 50:1274-1279

.

7.

Jonasson G, Carrlsen K, Sodaal A. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma.

European Respiratory Journal,

1999, 14:150-154

.

8. Milgrom I I et al. Noncompliance and treatment failure in children with asthma. Journal of Allergy & Clinical Inmunology.

1996, 98:1051-1057

.

9.

Mann MC et al. An evaluation of severity-modulated compliance with q.i.d. dosing of inhalated beclomethasone. Chest,

1992, 102:1342-1346.

10.

Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Social Science & Medicine.

1997, 45:189-201.

11.

Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest,

1998, 113:587-592.

12.

Chambers CV et al. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices

Respiratory Medicine,

1999, 93:88-94.

13.

Spurrier NJ et al. Association between parental perception of children’s vulnerability to illness and management of children’s asthma.

Pediatric Pulmonology,

2000, 29:88-93.

14.

Orrell-Valente JK, Jarlsberg LG, Hill LG, Cabana

MD.At

What Age Do Children Start Taking Daily Asthma Medicines on Their Own?

Pediatrics,

2008, 122:1186-1192.

15.

McQuaid E, Kopel S, Klein R, Fritz G. Medication Adherence in Pediatric Asthma: Reasoning, Responsibility, and Behavior. J. Pediatr.

Psychol,

2003, 28(5):323-333.

16.

Penza-Clive S, Mansell C, McQuaid E. Why Don’t Children Take Their Asthma Medications? A Qualitative Analysis of Children’s

Perspectives on Adherence. J Asthma.

2004, 41(2):189-97.

17.

Adams CD, Dreyer ML, Dinakar C, Portnoy JM. Pediatric asthma: a look at adherence from the patient and family perspective. Curr

Allergy Asthma Rep.

2004, 4(6):425-32.